Shelly K Ballentine

Title: Shelly K Ballentine: Innovator in Medical Chemistry

Introduction

Shelly K Ballentine is a prominent inventor based in Lansdale, PA (US), known for her significant contributions to the field of medical chemistry. With a total of two patents to her name, she has made remarkable strides in developing innovative treatments for various diseases.

Latest Patents

Her latest patents focus on inhibitors of C-FMS kinase. The inventions are directed to compounds of Formula I, which include solvates, hydrates, tautomers, and pharmaceutically acceptable salts that inhibit protein tyrosine kinases, particularly c-fms kinase. These compounds are designed to treat autoimmune diseases and conditions with an inflammatory component. They also address metastasis from various cancers, including ovarian, uterine, breast, prostate, lung, colon, and stomach cancers. Additionally, her inventions aim to alleviate pain associated with tumor metastasis, osteoarthritis, and other inflammatory conditions, as well as diseases like osteoporosis and Paget's disease.

Career Highlights

Shelly K Ballentine is currently associated with Janssen Pharmaceutica NV, where she continues to advance her research and development efforts. Her work has been instrumental in creating therapeutic solutions that improve patient outcomes.

Collaborations

Throughout her career, she has collaborated with notable colleagues, including Carl R Illig and Jinsheng Chen, contributing to a dynamic research environment that fosters innovation.

Conclusion

Shelly K Ballentine's contributions to medical chemistry exemplify her dedication to improving healthcare through innovative inventions. Her work in developing inhibitors of C-FMS kinase showcases her commitment to addressing critical health challenges.